Skip to content

DRMA

Dermata Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.21
−1.63%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$13
Net value (3m)
+1.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 18, 2026PROEHL GERALD T · director, 10 percent owner, officer: PRESIDENT, CHAIRMAN, CEOA-Award170,068$0.00
Aug 18, 2026PROEHL GERALD T · director, 10 percent owner, officer: PRESIDENT, CHAIRMAN, CEOA-Award1,360,544$1.47
Aug 18, 2026Van Hoose Kyri K. · officer: SVP, CFOA-Award102,040$0.00
Jun 16, 2026Scott Kathleen D. · directorSale11$1.19
Mar 17, 2026Bedoya-Toro Munera Maria E · officer: SVP, Regulatory AffairsPurchase1,000$1.27
Jan 6, 2026FISHER MARY · directorA-Award2,500$2.18
Jan 6, 2026Scott Kathleen D. · directorA-Award2,500$2.18
Jan 6, 2026Bedoya-Toro Munera Maria E · officer: SVP, Regulatory AffairsA-Award9,000$2.18
Jan 6, 2026HALE DAVID F · directorA-Award2,500$2.18
Jan 6, 2026PROEHL GERALD T · director, 10 percent owner, officer: President, CEO and ChairmanA-Award37,500$2.18
Jan 6, 2026WIERENGA WENDELL · directorA-Award2,500$2.18
Jan 6, 2026Nardo Christopher J. · officer: Senior VP, CDOA-Award18,000$2.18
Jan 6, 2026Sandler Andrew Seth · directorA-Award2,500$2.18
Jan 6, 2026Van Hoose Kyri K. · officer: SVP, CFOA-Award18,000$2.18
Jan 6, 2026Mento Steven J · directorA-Award2,500$2.18
Jan 6, 2026Bradrick Brittany · directorA-Award2,500$2.18
Dec 29, 2025Van Hoose Kyri K. · officer: SVP, CFOA-Award122,549$0.00
Dec 29, 2025PROEHL GERALD T · director, 10 percent owner, officer: PRESIDENT, CHAIRMAN, CEOA-Award78,740$2.04
Dec 29, 2025PROEHL GERALD T · director, 10 percent owner, officer: PRESIDENT, CHAIRMAN, CEOA-Award122,549$0.00
Dec 29, 2025PROEHL GERALD T · director, 10 percent owner, officer: PRESIDENT, CHAIRMAN, CEOA-Award490,196$2.04
Dec 29, 2025Van Hoose Kyri K. · officer: SVP, CFOA-Award7,874$2.04
Jan 23, 2025Van Hoose Kyri K. · officer: SVP, CFOA-Award78,741$0.00
Jan 23, 2025PROEHL GERALD T · director, 10 percent owner, officer: President, CEO and ChairmanA-Award787,402$0.00
Jan 23, 2025HALE DAVID F · directorA-Award78,741$0.00
Jan 23, 2025FISHER MARY · directorA-Award196,851$0.00
Jan 14, 2025WIERENGA WENDELL · directorA-Award5,000$1.38
Jan 14, 2025Sandler Andrew Seth · directorA-Award5,000$1.38
Jan 14, 2025Nardo Christopher J. · officer: Senior VP, CDOA-Award20,000$1.38
Jan 14, 2025Bradrick Brittany · directorA-Award5,000$1.38
Jan 14, 2025Bedoya-Toro Munera Maria E · officer: SVP, Regulatory AffairsA-Award8,000$1.38
Institutional positioning

13F filings over the trailing two quarters

New 4Increased 1Reduced 1Sold out 7
FilerActionSharesFiled
GEODE CAPITAL MANAGEMENT, LLCNew Position48,334May 15, 2026
UBS GROUP AGIncreased35,608May 5, 2026
WELCH & FORBES LLCNew Position20,000May 1, 2026
MCF ADVISORS LLCNew Position1,732May 11, 2026
TOWER RESEARCH CAPITAL LLC (TRC)Reduced716May 15, 2026
SBI SECURITIES CO., LTD.Unchanged101Apr 28, 2026
CITIGROUP INCNew Position1May 11, 2026
UBS Group AGSold Out0May 5, 2026
Tower Research Capital LLC (TRC)Sold Out0May 15, 2026
WELCH & FORBES LLCSold Out0May 1, 2026
GEODE CAPITAL MANAGEMENT, LLCSold Out0May 15, 2026
SBI Securities Co., Ltd.Sold Out0Apr 28, 2026
CITIGROUP INCSold Out0May 11, 2026
MCF Advisors LLCSold Out0May 11, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026